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The yeast mitochondrial proteins Rcf1 and Rcf2 support the
enzymology of the cytochrome c oxidase complex and
generation of the proton motive force
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The yeast mitochondrial proteins Rcf1 and Rcf2 are associ-
ated with a subpopulation of the cytochrome bc1– cytochrome c
oxidase supercomplex and have been proposed to play a role in
the assembly and/or modulation of the activity of the cyto-
chrome c oxidase (complex IV, CIV). Yeast mutants deficient in
either Rcf1 or Rcf2 proteins can use aerobic respiration– based
metabolism for growth, but the absence of both proteins results
in a strong growth defect. In this study, using assorted biochem-
ical and biophysical analyses of Rcf1/Rcf2 single and double
null-mutant yeast cells and mitochondria, we further explored
how Rcf1 and Rcf2 support aerobic respiration and growth. We
show that the absence of Rcf1 physically reduces the levels of
CIV and diminishes the ability of the CIV that is present to
maintain a normal mitochondrial proton motive force (PMF).
Although the absence of Rcf2 did not noticeably affect the phys-
ical content of CIV, the PMF generated by CIV was also lower
than normal. Our results indicate that the detrimental effects of
the absence of Rcf1 and Rcf2 proteins on the CIV complex are
distinct in terms of CIV assembly/accumulation and additive in
terms of the ability of CIV to generate PMF. Thus, the combined
absence of Rcf1 and Rcf2 alters both CIV physiology and assem-
bly. We conclude that the slow aerobic growth of the Rcf1/Rcf2
double null mutant results from diminished generation of mito-
chondrial PMF by CIV and limits the level of CIV activity
required for maintenance of the PMF and growth under aerobic
conditions.
Originally found through their physical association with the
cytochrome bc1– cytochrome c oxidase supercomplex of the
mitochondrial oxidative phosphorylation (OXPHOS)2 system,
the yeast Rcf1 and Rcf2 respiratory supercomplex–associated
factor proteins have been reported to support the cell’s ability to
perform aerobic respiration (1–6). Rcf1 and Rcf2 are yeast
members of the conserved Hig1 protein family (hypoxia-in-
duced gene 1 family) (7–10). Contrary to initial suggestions, the
presence of Rcf1 and Rcf2 is not required to achieve the III2–
IV1–2 supercomplex arrangement of the cytochrome bc1 (com-
plex III (CIII)) with the cytochrome c oxidase (complex IV
(CIV)) enzyme. Rather, evidence that Rcf1 supports the assem-
bly and activity of the CIV enzyme by physically associating
with it, possibly in a dynamic way to modify the enzyme and,
thereby, its stability and catalytic properties, has been pre-
sented (1, 4, 11–15). In addition, Rcf1 has been shown to phys-
ically interact with the newly synthesized Cox3 subunit prior to
Cox3’s assembly into the functional CIV enzyme (1, 16). Evi-
dence indicating that Rcf1’s “fingerprint” on the CIV complex
may involve association of lipids with the Cox3 subunit has also
been presented recently (11).
Cox1, Cox2, and Cox3 represent the core subunits of the CIV
enzyme, and all three are encoded on the mitochondrial
genome. The Cox1 and Cox2 subunits contain the heme (aa3)
and copper prosthetic groups essential for CIV catalysis and
thus are directly involved in the oxidation of cytochrome c and
the reduction of oxygen (O2) to water. Although Cox3 does not
bind metal and is not essential for electron transfer (ET), it does
bind cardiolipin and phosphatidylglycerol in a deep cleft
between its two transmembrane domains (17–19). Cox3 binds
to Cox1, and O2 flows through the lipids of Cox3 into the O2
translocation channel in Cox1 (18, 20, 21). The observed asso-
ciation of Rcf1 with newly synthesized Cox3 and reduced levels
of assembled CIV enzyme in the absence of Rcf1 suggest that
Rcf1 plays a role in the folding and/or lipid incorporation into
the Cox3 subunit prior to its assembly into CIV (1–3). Consis-
tently, misassembly of some CIV active sites in the absence of
Rcf1, as evidenced by altered cyanide binding and by a low
redox potential for heme a3, was recently reported (12, 13).
Consequently, maximum turnover rates of CIV enzyme are
reported to be lower in rcf1 than in WT mitochondria (520
s1 compared with 800 s1) (13). However, the role of the Rcf1
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and Rcf2 proteins after CIV assembly, particularly bioenergetic
consequences of the absence of Rcf1 and/or Rcf2, are unknown.
As an essential component of OXPHOS, CIV transfers elec-
trons from reduced cytochrome c to O2, a catalytic reaction
accompanied by the uptake of electrons and protons used in the
formation of water from opposite sides of the inner mitochon-
drial membrane (IMM). In addition, ET also drives the pump-
ing of protons completely across the IMM. Both O2 reduction
and proton pumping generate proton motive force (PMF),
almost all of which takes the form of an electrical potential ()
(22). PMF drives the proton translocation used by the F1Fo-
ATP synthase to effect ATP synthesis. The rate of catalytic
turnover by CIV is limited by the normal PMF of mitochondria
(180 mV, negative inside, positive outside). In isolated intact
mitochondria, addition of a bolus of ADP activates proton flow
through F1Fo-ATP synthase, driving ATP synthesis, which
leads to a transient decrease in PMF. OXPHOS ET, including
CIV, accelerates as the decreased density of the positive charge
on the outer surface of the IMM allows more rapid proton
pumping. Addition of an uncoupler (e.g. CCCP) to completely
dissipate the PMF removes any inhibition of proton pumping,
allowing CIV to reach maximal turnover rates for a given set of
substrate concentrations, i.e. reduced [cytochrome c], [H]
(pH), and [O2].
Yeast mutants deficient in either Rcf1 or Rcf2 proteins (i.e.
rcf1 and rcf2 strains) retain their ability to grow through
aerobic respiration– based metabolism, as evidenced by their
growth on nonfermentable carbon sources. In contrast, com-
bined deletion of the genes encoding both Rcf1 and Rcf2 results
in a strong defect in respiration-based growth of the resulting
double mutant, rcf1;rcf2 (1). The compromised ability to live
by respiration when both Rcf1 and Rcf2 are absent, as opposed
to when one or other are absent, indicates that these proteins
may share overlapping functions or that they have distinct
functions and their combined absence compromises OXPHOS
capacity below a threshold critical to support aerobic growth.
In this study, we sought to gain further understanding of the
significance of the Rcf1 and Rcf2 proteins for the bioenergetics
of CIV and the OXPHOS system. We report here that, in the
absence of Rcf1, the physical content of the CIV enzyme is
reduced and a decline in PMF, independent of the lower con-
tent of CIV, is detected when electron transport activity
through the CIV enzyme is induced. In contrast, the CIV
enzyme levels are not strongly affected by the absence of Rcf2.
However, evidence for a reduced ability of the CIV to gener-
ate PMF was also obtained in rcf2 mitochondria, suggesting
that Rcf2 may also be required to ensure normal PMF pro-
duction by the CIV. The combined absence of both Rcf1 and
Rcf2 (i.e. rcf1; rcf2 mitochondria) strongly diminished the
ability of yeast mitochondria to maintain a normal mem-
brane potential. Analysis of the overall data suggests that
CIV is the source of the  maintenance defect when Rcf1/
Rcf2 proteins are absent. We speculate a role for Rcf1/Rcf2
proteins in maintaining the integrity of the CIV enzyme in a
manner that involves the Cox3 subunit and its association
with its integral lipids.
Results
The mitochondrial physical content of the CIV is negatively
impacted by the absence of Rcf1 but not Rcf2
To extend our previous analyses of the consequences caused
by the absence of Rcf1 and/or Rcf2 on the content of mitochon-
drial OXPHOS complexes (1), we initially analyzed the cyto-
chrome content of Rcf1/Rcf2 single- and double-null mutant
mitochondria using dithionite reduced-ferricyanide oxidized
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Figure 1. The levels of CIV complex are reduced in the absence of Rcf1. A,
spectral analysis of total mitochondrial cytochromes. Mitochondria (1 mg)
isolated from the indicated strains were solubilized in DDM (2%), and differ-
ence spectra of reduced (sodium dithionite) minus oxidized (potassium ferri-
cyanide) mitochondrial cytochromes (aa3, b, and c, c1) were recorded. B,
steady-state levels of the indicated OXPHOS subunits in isolated mitochon-
dria (25 g) were analyzed by Western blotting. The resulting signals were
quantified following scanning using Image Studio software and normalized
to the loading control Tim44. The positions of the molecular mass standards
are indicated. C, mitochondria (30 g) isolated from the indicated strains
were solubilized in DDM (0.6%) and subjected to BN-PAGE analysis, Western
blotting, and immunodecoration with antibodies against the complex III sub-
unit Qcr7 (-Qcr7) or complex IV subunit Cox3 (-Cox3) was performed. D, the
same as in C, except that mitochondria were solubilized with digitonin (1.0%)
prior to BN-PAGE, and decoration was performed with antibodies against the
complex III subunit cytochrome c1 (-Cytc1). E and F, specific activities of the
cytochrome bc1 (E, NADH-cyt c reductase, n  9) and CIV (F, Cyt c oxidase, n 
4 –23) enzymes were measured in detergent-solubilized mitochondria as
described under “Experimental procedures.” Activities are expressed as a per-
centage of the WT control. Values represent average 	 S.E. ****, p 
 0.0001;
**, p 
 0.01. 1, rcf1; 2, rcf2; 1;2, rcf1;rcf2; OD, optical density.
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















mined from the cytochrome aa3 peak at 603 nm, was similar to
the WT in the rcf2 mitochondria but 50% reduced in rcf1
mitochondria. Notably, the CIV levels were not further reduced
when Rcf2, in addition to Rcf1, was absent, as the cytochrome
aa3 levels in the rcf1;rcf2 mitochondria were found to be
similar to those in rcf1 mitochondria (Fig. 1A and Table S1).
This indicates that the loss of Rcf2 in addition to Rcf1 does not
have an additive negative consequence for the physical content
of CIV. Little impact on cytochrome c:c1 spectral levels (550
nm) were observed when Rcf1 and/or Rcf2 were absent. How-
ever, the amount of b-type cytochromes (560 nm) was slightly
increased over the WT control in the absence of Rcf2 (in both
rcf2 and rcf1; rcf2 mitochondria) (Fig. 1A and Table S1).
SDS-PAGE analysis of isolated mitochondrial proteins con-
firmed that the levels of cytochromes c1, c, and b were not
reduced in the mutant strains (and were even slightly elevated
in the absence of Rcf2). Consistent with the cytochrome aa3
spectral analysis, the content of Cox1 was significantly reduced
in rcf1 and rcf1;rcf2 mitochondria but not in rcf2 mito-
chondria (Fig. 1B).
The assembly profiles of CIII and CIV were also analyzed by
blue native PAGE analysis (BN-PAGE) (Fig. 1C). Two forms of
CIV, complexes IV and IV*, which differ in the association of
subunit Cox12 with the CIV enzyme (11), are detected from
WT mitochondria following solubilization in 0.6% dodecyl
maltoside (Fig. 1C, bottom panel). A strong reduction in both
IV/IV* forms was observed in the absence of Rcf1, and a similar
reduction was obtained in rcf1;rcf2 mitochondria. The
absence of Rcf2 alone did not have any apparent negative
impact on CIV accumulation, which was similar to the WT
control. The cytochrome bc1 complex (III2) appeared to be
largely unaffected by the absence of Rcf1 and/or Rcf2 (Fig. 1C,
top panel).
Solubilization of the isolated mitochondria with digitonin (a
milder detergent than dodecyl maltoside) allowed examination
of III2–IV1–2 supercomplex organization. Compared with the
WT, the lower content of CIV in the absence of Rcf1 led to
decreased amounts of the III2–IV2 supercomplex, an increase
in the III2–IV1 supercomplex, and accumulation of free dimeric
CIII (III2) (Fig. 1D). Similar changes were observed in rcf1;
rcf2 mitochondria. In contrast, rcf2 mitochondria showed a
supercomplex profile similar to the WT, and no free dimeric
CIII was seen (Fig. 1D), consistent with our previous findings
(1).
The ET activities of detergent-solubilized cytochrome bc1
and CIV, analyzed spectrophotometrically for rates of exoge-
nous cytochrome c reduction and oxidation, respectively (Fig.
1, E and F, and Table S2), yielded results consistent with the
protein gels and cytochrome content analyses. The cytochrome
c reduction assay showed that the activity levels of the cyto-
chrome bc1 complex were similar in WT, rcf1, and rcf2
mitochondria and even somewhat elevated in rcf1;rcf2 mito-
chondria (Fig. 1E). The cytochrome c oxidation assay, on the
other hand, indicated that the relative specific activities of the
CIV enzyme in rcf1 and rcf1;rcf2 mitochondria were
strongly reduced and to similar extents (31% and 27%, respec-
tively, of the WT control) (Fig. 1F and Table S1). Less of a
reduction in CIV activity was observed in the rcf2 mitochon-
dria, again consistent with the protein gels and cytochrome
content analyses.
The specific activity of CIV was also independently measured
in intact mitochondria using ascorbate/TMPD to donate elec-
trons to endogenous cytochrome c and measuring its O2 con-
sumption rate. Measurements were performed in the presence
of the uncoupler CCCP to avoid inhibition of CIV activity by
PMF. Under these conditions, CIV in rcf1 and rcf1;rcf2
mitochondria showed 37% and 28% of the activity CIV in WT
mitochondria, respectively, whereas the activity of CIV in rcf2
mitochondria was 70% of the WT (Fig. S1 and Table S2). Hence,
both methods of measuring CIV activity gave similar results
(Fig. 1F versus Fig. S1 and Table S2). Our finding that the CIV
enzyme–specific activities are lower than the CIV accumula-
tion levels indicated by the protein gels and by the spectropho-
tometric analyses indicates that the molecular activities of CIV
in each of the Rcf mutant mitochondria must be lower than CIV
in WT mitochondria.
In summary, we conclude that the physical levels of the CIV
enzyme are negatively impacted by the absence of Rcf1. How-
ever, the absence of Rcf2 has little effect on the content of CIV.
Cells deficient in Rcf2 exhibit enhanced respiration and
sensitivity to K/H ionophore and hypoxic conditions
We have reported previously that cells deficient in Rcf1 or
Rcf2 can still grow on nonfermentable carbon sources (i.e. res-
piration-based growth) but that growth of the double rcf1;
rcf2 mutant is strongly impaired under these conditions (1,
11). To determine whether the observed respiration-based
growth defect of the rcf1;rcf2 mutant is due to a compro-
mised O2 consumption capacity and/or a reduction in the mito-
chondrial content of these cells, we analyzed whole-cell respi-
ration in the Rcf1/Rcf2 mutants and the levels of mitochondria
in their whole-cell extracts (Fig. 2). The cellular O2 consump-
tion rates in rcf1 and rcf1;rcf2 cells were close to those of
WT cells, despite the significantly lower CIV content of their
mitochondria. The O2 consumption profile of rcf2 cells was
significantly elevated with respect to the WT control and single
Rcf1/Rcf2 mutants (OCR of rcf2 cells was 140% that of the WT
levels) (Fig. 2A). The mitochondrial content of the Rcf1/Rcf2
mutant cells was found not to greatly differ from those of the
WT cells, as indicated by the levels of mitochondrial proteins
such as porin (an outer mitochondrial membrane protein) and
Tim17 (an IMM protein) relative to the cytosolic marker pro-
tein Pgk1 (Fig. 2B). Consistent with the observed decrease in
the steady-state levels of CIV in the isolated mitochondria doc-
umented in Fig. 1, the levels of Cox3 were strongly reduced in
rcf1 and rcf1; rcf2 cells and, to a lesser extent, in rcf2 cells
(Fig. 2B). Taken together, these results indicate that the
impaired ability of rcf1;rcf2 cells to grow through respira-
tion-based metabolism is not due to an inability to respire, i.e.
consume O2, or reduced cellular mitochondrial content.
The significantly increased level of respiration in rcf2 cells
relative to their mitochondria and CIV/cytochrome aa3 con-
tent may be indicative of partial uncoupling. Consistent with
this suggestion, we observed that respiration-based growth of
the rcf2 strain was compromised when grown under hypoxic
conditions (2% O2; expected to slow mitochondrial ET and
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















ATP synthesis) relative to the WT strain under the same [O2]
condition or the rcf2 strain grown under normoxia conditions
(Fig. 2C). In addition, we observed that the rcf2 and rcf1;
rcf2 strains (but not the rcf1 or WT control strains) were
hypersensitive to low levels of nigericin when grown on galac-
tose medium (Fig. 2D). Nigericin is a K/H ionophore that
dissipates pH of the PMF (but not the charge component,
), and its action is specific to the IMM (23). The concentra-
tion of nigericin used was subtoxic for WT respiration, i.e. it
strongly reduced but did not completely inhibit respiration-
based growth (glycerol) of WT control cells (data not shown).
Galactose is a fermentable carbon source that favors respira-
tion-based growth (galactose does not repress mitochondrial
respiration like glucose does) and, consequently, the rcf1;
rcf2 strain exhibits a lower growth capacity on this medium
(Fig. 2D). The observed hypersensitivity of rcf2 (and the rcf1;
rcf2 strain) to nigericin suggests that the mitochondria’s abil-
ity to establish and/or maintain a normal PMF is compromised
when Rcf2 is absent, a finding consistent with the increased rate
of cellular O2 consumption by the rcf2 strain. In summary,
although the rcf2 cells can still grow on glycerol-based
medium, i.e. survive by respiration, the observed elevated O2
consumption profile and hypersensitivity to hypoxia and nige-
ricin are consistent with compromised ability of the rcf2
mutant to achieve or maintain an optimal PMF, which is critical
for OXPHOS coupling.
Deletion of RCF1 and RCF2 cumulatively lowers OXPHOS
coupling
Our results so far indicate that the absence of Rcf1 is corre-
lated with a physical reduction in CIV enzyme content.
Although the CIV levels are not as strongly reduced in the
absence of Rcf2, our data suggest that the mitochondria’s ability
to maintain a normal PMF in the absence of Rcf2 may be
impaired. On the basis of these data, we hypothesize that the
combination of both of these defects may be underlying the
observed respiration-based growth defect of the rcf1;rcf2
strain, as, unlike their respective single mutants, the PMF gen-
erated in the absence of both Rcf1 and Rcf2 may not be suffi-
cient to support normal rates of mitochondrial ATP synthesis.
To test this hypothesis, we evaluated the O2 consumption pro-
file of the isolated Rcf1/Rcf2 mutant mitochondria for indica-
tions of their ability to generate and maintain PMF.
We initially measured the basal O2 consumption rate (OCR)
(state 2) of the ET chain of the OXPHOS system by adding the
respiratory substrate NADH to isolated intact mitochondria
(Fig. 3A). In yeast mitochondria, ET from NADH to O2 involves
an NADH dehydrogenase that does not generate PMF and CIII
and CIV, which do. In normal coupled mitochondria, ET is
inhibited by PMF, particularly in the absence of proton transfer
through ATP synthase (state 2 conditions). For example, WT
mitochondria uncoupled with CCCP exhibited a rate of 900
nmol O2 min1 mg protein1 for ET from NADH to O2 (Fig.
S2C), but the PMF developed under state 2 conditions slows ET
to 170 nmol O2 min1 mg protein1 (Fig. 3A). In the presence
of CCCP, uncoupled O2 consumption driven by NADH in
rcf1 and rcf1;rcf2 mitochondria was 45% less than that of
the WT (Fig. S2C), consistent with the strongly reduced con-
tent of CIV in these mitochondria. However, in the absence of
CCCP, the state 2 O2 consumption driven by NADH was faster
in all three mutant mitochondria than in the WT control (Fig.
3A and Table S3), suggesting a diminished PMF in these mito-
chondria. The highest state 2 OCR rates were obtained when
Rcf2 was absent (i.e. in rcf2 and rcf1;rcf2 mitochondria),
where the elevated OCR in rcf2 mitochondria is particularly
relevant when one considers that the level of CIV was not as
impacted by the absence of Rcf2 (Fig. 1). Normalization of the
state 2 OCR to the physical content of CIV (i.e. cytochrome aa3
content) rather than to total mitochondrial protein generates
data showing the rate of ET per complete ET chain (Fig. S2A).
By this method, obvious increases in state 2 ET are observed in
all three mutant mitochondria relative to the WT control, fur-
ther supporting that the mitochondria may have a diminished
PMF when Rcf1 and/or Rcf2 are absent (Fig. S2A).
B









































Figure 2. Cellular respiration and stress sensitivity are enhanced in the
absence of Rcf2. A, endogenous cellular respiration was measured in the
indicated YPGal-grown yeast cultures (A600  0.6) (starting concentration,
270 M O2) using a Clark-type oxygen electrode at 30 °C. KCN-sensitive OCR
is shown, expressed as percent of the WT (n  2). Values represent average 	
S.E. **, p 
 0.01. B, whole-cell protein extracts from YPGal-grown cultures
(A600  0.6) were analyzed by SDS-PAGE and Western blotting using antibod-
ies to 3-phosphoglycerokinase (Pgk1), mitochondrial outer membrane porin
(Por1), and complex IV subunit 3 (Cox3). Signals were quantified as described
under “Experimental procedures” and normalized to the loading control
Pgk1. The positions of the molecular mass standards are indicated. C, cell
suspension serial dilutions spotted onto YPG medium and incubated at 21 °C
for 5 days under normoxia (21% oxygen) or hypoxia (2% oxygen), as indi-
cated. D, cell suspension serial dilutions were spotted on YPGal medium with
or without nigericin (1 M), as indicated, and incubated at 30 °C for 5 days. 1,
rcf1; 2, rcf2; 1;2, rcf1;rcf2.
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















When ATP synthase was activated by addition of ADP (state
3), NADH-driven OCR increased in the WT control because
proton flow through Fo-ATP synthase partially dissipated
the PMF and stimulated ET activity by CIII and CIV (Fig. 3B).
The rate of state 3 OCR driven by NADH was less stimulated by
ADP in rcf1 and rcf1;rcf2 mitochondria relative to control
WT mitochondria (Fig. 3B and Table S3). Consequently, the
calculated respiratory control ratios (RCR, i.e. the state 3/state 2
ratios) were lower in the absence of Rcf1, indicating loss of
OXPHOS coupling in rcf1 mutant mitochondrial types (Fig.
3C); the ratio of state 3 to state 2 ET is a standard measure of the
degree to which PMF affects mitochondrial ET. The lowered
RCR of the Rcf1/Rcf2 mutant mitochondria was obtained in
numerous independent preparations, supporting that it was
not due to a poor preparation of uncoupled (i.e. not intact)
mitochondria. Independently, we measured the exchange of
ADP and ATP through the ADP/ATP carrier (AAC) protein,
also known to associate with Rcf1 (1, 11). AAC activity was not
altered in the absence of Rcf1 and Rcf2 (data not shown); there-
fore, the observed decrease in the rate of state 3 respiration in
the absence of Rcf1 cannot be attributed to potentially limiting
ADP levels within the mitochondria.
When monitoring the NADH-driven state 2 respiration pro-
file, we observed that the OCR increased over time in rcf1;
rcf2 mitochondria and, to a lesser extent, in rcf1 mitochon-
dria, suggesting that the induction of electron transport
through the ET chain in the absence of Rcf1 may cause further
uncoupling (Fig. 3D). In contrast, the OCR was stable in WT
and rcf2 mitochondria. The gradual increase in OCR observed
in rcf1;rcf2 mitochondria was not prevented by addition of
the F1Fo-ATP synthase inhibitor oligomycin or atractyloside,
an inhibitor of the AAC protein (data not shown), suggesting
that a potential proton leak through either the Fo sector of the
enzyme or the AAC protein was not a contributing factor.
Following the consumption of exogenously added ADP, the
NADH-driven state 4 OCR of WT mitochondria, as expected,
returned to a level that was similar to the measured state 2 OCR
prior to ADP addition (i.e. state 4 OCR  state 2 OCR) (Fig. 3E).
rcf2 mitochondria displayed a similar property. However, this
was not the case for rcf1 and rcf1;rcf2 mitochondria, which
displayed a higher “state 4” level following ADP consumption
(Fig. 3E). To account for the kinetic variations in state 2 OCRs
between the different mutant types, the level of ADP-stimu-
lated O2 consumption occurring at the time of peak state 3 was
calculated for each mitochondrial type (i.e. state 3 minus state 2
OCRs at the peak time), and this further illustrated the com-
promised OXPHOS coupling capacity in the all three of the
Rcf1/Rcf2 mutant mitochondria (Fig. S2B). These observations,
taken together, indicate an underlying issue establishing and/or
maintaining the required PMF in the absence of Rcf1 and Rcf2,
limiting OXPHOS state 3 performance and, thus, ATP synthe-
sis capacity.
The ability of the ET chain system to support the PMF is
impaired in the absence of Rcf1/Rcf2
The ability of the ET chain system in Rcf1/Rcf2 mutant mito-
chondria to establish and maintain a normal PMF was next
investigated using the membrane potential indicator fluores-
cent dye safranin (24) (Fig. 4). Safranin is a lipophilic yet cati-













































































































Figure 3. Changes in state 2 and state 3 respiration in mitochondria from the rcf1, rcf2, and rcf1;rcf2 mutants. A, OCR (nanomoles O2 per minute
per milligram of isolated mitochondria) was measured in 0.5 ml of respiration buffer containing isolated mitochondria (40 g) following addition of NADH (1
mM) (state 2) as detailed under “Experimental procedures.” Values represent the average rate over the 2- to 8-min range 	 S.E. ***, p 
 0.001; **, p 
 0.01. B, OCR
was measured following addition of NADH (1 mM) and ADP (200 M) (state 3). Peak OCR is reported. Values represent average 	 S.E. *, p 
 0.05. C, RCR was
calculated by dividing the peak state 3 OCR (B) by the recorded state 2 OCR (A). D, state 2 respiration measured as in A and kinetically monitored for 8 min. The
calculated rate of OCR at each time point recorded is indicated. E, the state 2 OCR was initially recorded in the presence of NADH for 3 min, after which ADP (100
M) was added. The OCR was kinetically followed for another 7 min. Values represent average 	 S.E. ****, p 
 0.0001; **, p 
 0.01. 1, rcf1; 2, rcf2; 1;2,
rcf1;rcf2.
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















portion to the , i.e. in proportion to the density of negative
charge on the matrix surface of the inner membrane. When
inside, safranin aggregates and self-quenches. Therefore, the
extent of loss of safranin fluorescence in the presence of iso-
lated mitochondria indicates the extent of membrane potential
formation.
During ET from NADH to O2,  is generated by CIII and
CIV. During state 2 ET, the maximum uptake of safranin by
rcf1;rcf2 mitochondria was 30% lower than that of the WT
control (Fig. 4A and Table S4), corresponding to a 45% decline
in the estimated  (in millivolts, see “Experimental proce-
dures”) during steady-state ET (Fig. S3A). The uptake of safra-
nin was also lower in rcf1 and rcf2 single mutants, 83% and
95% of the WT, respectively (Fig. 4A), corresponding to 
declines of 27% in the absence of Rcf1 and 14% in the absence of
Rcf2 (Fig. S3A and Table S4). We conclude, therefore, that the
PMF was partially diminished in the absence of either Rcf1 or
Rcf2 but more significantly compromised when both proteins
were absent. In terms of “rescuing” the  defect of the double
Rcf mutant during ET from NADH to O2, Rcf1 appeared to be
more effective than Rcf2.
More information on the ability of WT and rcf1;rcf2 mito-
chondria to establish a PMF was extracted from the analysis of
kinetic traces of safranin uptake during ET (Fig. 4B). The intro-
duction of normal (WT) mitochondria in the assay mixture
containing 2 M safranin initiates a slow rate of O2 consump-
tion driven by endogenous substrates in the mitochondrial
matrix (30 pmol O2 s1  ml). This slow rate of ET is suffi-
cient to generate a potential across the IMM that drives the
uptake of 83% of the available safranin (Fig. 4B, black trace) for
an estimated  of 150 mV. The addition of 0.5 mM NADH
speeds ET in the reaction chamber 12-fold. This increases the
percent safranin uptake to 86%, corresponding to an estimated
 of 169 mV.
When the rcf1;rcf2 mitochondria were analyzed in paral-
lel (Fig. 4B, gray trace), two significant changes from the results
obtained with WT mitochondria were observed. First, the
mitochondria from the rcf1;rcf2 strain exhibited a 45% lower
maximum  than that of WT mitochondria, as discussed
above. Second, the more rapid state 2 ET initiated by NADH
triggered a progressive loss of  during continuous ET, seen
as an increase in safranin fluorescence. This phenomenon was
always observed in rcf1;rcf2 mitochondria but not in mito-
chondria isolated from the single Rcf deletion mutants (data
not shown). The trace of ET-driven loss of  in rcf1;rcf2
mitochondria does not proceed to complete collapse of .
ET-driven loss of  was not altered by addition of either oli-
gomycin or atractyloside (data not shown), indicating that ET
was not activating a proton leak through either ATP synthase or
the adenine nucleotide translocator.
We conclude that the ability of the ET chain system to gen-
erate and/or maintain  is compromised in the absence of
Rcf1 and Rcf2. This explains the lower RCR values and the
increases in state 2 ET observed for the Rcf mutants (Fig. 3, A
and C). Moreover, progressive loss of  may be the cause of
the increasing rate of O2 consumption observed in rcf1;rcf2
mitochondria during state 2 ET from NADH to O2 (Fig. 3D).
The compromised ability of the Rcf mutants to generate and/or
maintain  when supplied with NADH could arise from a
decreased ability of CIV to generate PMF and was next directly
analyzed.
The Rcf1 and Rcf2 proteins are necessary for CIV to generate a
normal membrane potential
Using ascorbate/TMPD as an electron donor to bioenerget-
ically isolate the CIV enzyme in intact mitochondria, we
directly measured the CIV’s O2 consumption and  genera-
tion activities. The state 2 OCRs of CIV in rcf1, rcf2, and
rcf1;rcf2 intact mitochondria (i.e. in the presence of a PMF
and absence of ATP synthesis) were determined to be 54%, 78%,
and 45% of the WT control levels, respectively (Fig. 5A and
Table S2), consistent with the reduced CIV physical levels in the
absence of Rcf1 (Fig. 1).
We next measured the maximum  (maximum safranin
fluorescence quenching) developed by state 2 ET through the
CIV enzyme alone for each mitochondrial type (Fig. 5B and
Table S4). Measurements were performed in the presence of
antimycin A to inhibit complex III. To avoid complications
arising from differing amounts of CIV between the mitochon-
drial types, we matched the ET rates through CIV for each of
the mitochondrial forms during the measurements of  (Fig.
S3B, left panel, and Table S4). CIV activity was adjusted by
varying the amounts mitochondria used in the different assays
between 100 and 200 g (mitochondrial protein). With similar
rates of ET through each CIV form, both the decreased
amounts of CIV seen in the absence of Rcf1 and the lower
molecular activities of CIV in the Rcf deletion mutants cease to
be factors that influence the outcome. Rather, the assay deter-
mines to what extent each CIV form can convert the same
amount of redox energy into PMF. Plots of the amount of mito-
chondria versus safranin uptake indicated that changes in
matrix volume had no significant effect on the measured values
of  (data not shown).
The CIV-driven maximum safranin uptake values exhibited
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Figure 4. Measurements of state 2 membrane potential in mitochondria
isolated from the rcf1, rcf2, and rcf1;rcf2 mutants. A, maximum val-
ues for percent safranin uptake as an indicator of  were measured for state
2 ET from 0.5 mM NADH to O2 as described under “Experimental procedures.”
The corresponding  values in millivolt are presented in Fig. S3A and Table
S4. In these data, there was no significant difference in the average ET rates in
the reaction chamber for any of the mitochondrial types (data not shown).
Therefore, any changes in percent safranin uptake (as well as in estimated
) did not result from altered rates of ET through CIII and CIV. Values repre-
sent the average 	 S.E. n  14 –22; ****, p 
 0.0001; **, p 
 0.01. B, represen-
tative kinetic traces of safranin fluorescence during state 2 ET from NADH to
O2 as described in the text and obtained as described under “Experimental
procedures.” 1, rcf1; 2, rcf2; 1;2, rcf1;rcf2.
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















that of the WT, respectively, whereas rcf1;rcf2 mitochondria
showed a 40% decline (Fig. 5B). These values correspond to
estimated millivolt declines of 10% and 18% for rcf1 and rcf2
CIV, respectively, and a 33% decline in  for rcf1;rcf2 CIV
(Fig. S3B). This pattern is similar to that observed for the 
values obtained during state 2 ET from NADH to O2, with the
exception that the  obtained in the absence of Rcf1 is slightly
greater than that of rcf2, rather than less. Thus, with  sup-
ported by CIV alone, Rcf2 appears to be slightly better in res-
cuing the  defect of the double Rcf mutant than Rcf1. Con-
sistent with the measurements of  during NADH-driven ET
(Fig. 4B), rcf1;rcf2 mitochondria exhibited the phenomenon
of progressive loss of  during continuous ET through CIV
(seen as an increase in safranin fluorescence, i.e. loss of quench-
ing, over time) (Fig. 5C).
Taking these results together, we conclude that the ability of
yeast mitochondria to generate and maintain their membrane
potential is negatively impacted by the absence of Rcf1 or Rcf2
and that the effects of these proteins on  are additive. As the
progressive loss of  is observed with ET driven through CIV
alone, we propose that CIV is the source of that phenomenon
and that CIV is also responsible for the decrease in maximum
 observed when both Rcf proteins are absent.
Discussion
We demonstrate here that the absence of Rcf1 is correlated
with a significant decrease in the physical content of the CIV
enzyme (Fig. 1) and an impaired ability of the mitochondria to
generate and maintain normal PMF. NADH-driven ET in rcf1
mitochondria was less repressed by state 2 conditions than in
WT mitochondria (Fig. 3A and Table S3), suggesting uncou-
pling, consistent with the lower RCR value determined for
rcf1 mitochondria (Fig. 3C). Indeed, the maximum  devel-
oped during NADH-driven ET was 27% less than that of the
WT (Fig. S3A and Table S4). When bioenergetically isolated
using ascorbate/TMPD as substrate, CIV of rcf1 mitochon-
dria produced 10% less maximum  than the WT control
(Fig. S3B and Table S4). It is important to note that the 
measurements were obtained using conditions where the rate
of ET in the Rcf1/Rcf2 mutant mitochondria were similar to
WT control mitochondria. Thus, the lower  values obtained
for Rcf1/Rcf2 mutant mitochondria do not result from the
lower physical content of CIV in these mitochondria. Although
rcf1 mitochondria exhibited decreased CIV content and a
lowered capacity to generate , respiration-based growth of
rcf1 cells was not affected.
CIV was present in rcf2 mitochondria (and cells) at normal
or near-normal levels (Fig. 1), strongly indicating that Rcf2,
unlike Rcf1, does not play a critical role in CIV assembly/stabil-
ity. However, similar to Rcf1, the presence of Rcf2 is required
for the normal generation of PMF by CIV. First, the rcf2 strain
exhibited elevated levels of cellular respiration, along with
hypersensitivity to hypoxia and to subtoxic levels of the K/H
ionophore nigericin (Fig. 2). Second, ET from NADH to O2 in
rcf2 mitochondria was less repressed by state 2 conditions
than the WT, and the determined RCR was less than that of the
WT (Fig. 3, A and C). During state 2 ET, rcf2 mitochondria
generated 14% less  than WT for NADH3O2 (CIII plus
CIV; Fig. S3A) and 18% less  for ascorbate/TMPD3O2
(CIV alone; Fig. S3B).
The absence of both Rcf1 and Rcf2 resulted in the same
decrease in the content of CIV as seen in rcf1 mitochondria
(Fig. 1), reinforcing the conclusion that Rcf2 has little or no
effect on CIV assembly. ET in rcf1;rcf2 mitochondria shows
the least PMF response to state 2 conditions, and the RCR is the
lowest of the mutant mitochondrial forms (Fig. 3, A and C). The
ability of ET from NADH or by CIV alone to generate  was
severely compromised in rcf1;rcf2 mitochondria relative to
the respective single mutants and to the WT control, indicat-













































































Figure 5. Capacity of CIV to contribute to the mitochondrial membrane
potential during state 2 ET. A, mitochondria (40 g) isolated from the indi-
cated strains were suspended in respiration buffer, and the OCR driven by
electron flow directly to the CIV enzyme via ascorbate (12.5 mM) and TMPD
(1.4 mM) was recorded. Values represent the average 	 S.E. n  5–11; ****, p 

0.0001; **, p 
 0.01. B, maximum values for percent safranin uptake as an
indicator of  were measured for state 2 ET through CIV, as described under
“Experimental procedures.” The corresponding  values in millivolt are pre-
sented in Fig. S3B and Table S4. Values represent the average 	 S.E. n  6 –16;
****, p 
 0.0001; ***, p 
 0.001. C, representative kinetic traces of safranin
fluorescence during state 2 ET through CIV as described in the text and
obtained as described under “Experimental procedures.” 1, rcf1; 2, rcf2;
1;2, rcf1;rcf2.
Rcf1/Rcf2 support maintenance of mitochondrial PMF by CIV






















Rcf2 absence on the production of  are cumulative. The
combined effect of the absence of both Rcf1 and Rcf2 proteins,
i.e. the reduced CIV content and the lower , results in inabil-
ity of the OXPHOS system to sustain normal rates of respira-
tory growth.
In addition to producing the lowest maximum  values, the
absence of Rcf1 and Rcf2 leads to the interesting phenomenon
of progressive loss of  over time (Figs. 4B and 5C). Induction
of the progressive loss of  was observed to require ET and,
thus, most likely arises from an ET complex. This limits the
sources to CIII or CIV, and because progressive loss of  is
observed using CIV alone, we assign the phenomenon to CIV.
Induction of progressive loss of  requires a rate of ET greater
than 60 pmol O2 sec1 through CIV because it is not observed
during oxidation of endogenous substrates (Fig. 4B) but seen
when the ET rate jumps 12-fold with addition of NADH. The
kinetics of the progressive loss of  in Fig. 5C fit well to a
single exponential (data not shown), indicating that a popula-
tion of CIV is structurally poised to lose some ability to generate
 because of a change that occurs during continuous catalytic
turnover. This labile population is likely a subset of the total
amount of CIV because in the exponential fit  does not
decline to zero but rather plateaus at a nonzero value.
Given that the progressive loss of  arises from CIV, the
most likely source for the decreased ability of all three of the Rcf
mutants to generate  (i.e. lower maximum ) is abnormal
CIV function. The next question is whether abnormal CIV cre-
ates a transmembrane proton leak that causes the decline in 
or whether the actual generation of  by CIV is altered, i.e.
whether some population of CIV is pumping fewer protons per
catalytic cycle. These options cannot be easily distinguished
because the results are identical: a lower . However, dimin-
ished proton pumping seems more probable on mechanistic
grounds. Proton pumping by CIV requires a number of proton
gates to prevent proton backflow, i.e. “slipping” of the pump
proton back to the negative surface of the IMM (21, 25). Only
one proton gate needs to be compromised to lower the effi-
ciency of proton pumping, whereas all of the proton gates must
be overcome to have transmembrane proton leak through CIV.
There exists precedence for decreased efficiency of proton
pumping by CIV, and this precedent involves the assembly tar-
get of Rcf1, Cox3 of CIV (1, 11). The structure of Cox3 includes
a specifically bound complement of lipids, up to four phos-
phatidylglycerols plus one cardiolipin (19, 20). It has been dem-
onstrated previously that correct lipid binding within Cox3 is
necessary for the subunit to prevent structural changes at the
active site in Cox1 that lead to suicide inactivation during con-
tinuous ET (18, 19). In fact, a likely role for Rcf1 in the assembly
of Cox3 is to facilitate the insertion of its lipids (11), and we
further proposed that Rcf1 dynamically associates with CIV (via
Cox3 and possibly Cox12) to support CIV function throughout
its lifespan by maintaining the complement of specific lipids
bound within Cox3 (1, 11). The altered association of Cox12
and Cox13 with the CIV enzyme, which is observed in the
absence of Rcf1 and Rcf2 proteins (1, 3), may add support for an
altered arrangement of Cox3 within the CIV complex.
In addition to preventing suicide inactivation of CIV (19), it is
well-established that Cox3 controls the efficiency of proton
pumping. The absence of Cox3 decreases the H/eO stoichi-
ometry of proton pumping by 50% for both bacterial and
mitochondrial CIV (26 –28). The reason for the decreased effi-
ciency of pumping without Cox3 is likely a structural change
that raises the pKa of a key pump proton transfer group located
in Cox1 near the O2 reduction site (19, 29, 30). Indeed, evidence
for a role of Rcf1 in supporting the structure of the heme a3-CuB
O2 reduction site of CIV has been presented by Brzezinski and
co-workers (12–15). Cox3 plays a role in preventing the active-
site alterations documented by Brzezinski and co-workers (19,
31) via long-range interactions with the Cox1 subunit. Cox3 is
present in CIV of the Rcf mutants, but it is possible that the
integral lipids of Cox3 may be disturbed because of misassem-
bly and/or lack of maintenance (11). Here we propose that cor-
rect lipid binding within Cox3 is required to maintain the envi-
ronment of proton pump residues near the active site that are
required for normal proton pumping. We further propose that
the Rcf1/Rcf2 proteins serve to ensure the correct folding/re-
folding of Cox3 and the integrity of its lipid association, perhaps
as lipid chaperones, both during the initial assembly of Cox3
into CIV and also during the lifespan of CIV. For example, the
Rcf proteins may function to repair lipid binding defects in
Cox3 caused by movements in Cox1 as a consequence of the
catalytic cycle. In this scenario, a given mitochondrion would
contain subpopulations of CIV physically in association with
the Rcf1/Rcf2 proteins, being “fixed” to minimize suicide inac-
tivation and maintain the efficiency of proton pumping.
Overall, we demonstrate here that the yeast Rcf1 and Rcf2
proteins support the generation and maintenance of PMF by
CIV and, thus, that Rcf1/Rcf2 are essential for respiratory
growth under optimal and suboptimal conditions. Rcf1 and
Rcf2 are members of the Hig1/HIGD1 family of proteins. In
mammals, the family also includes stress-induced Hig1/HIGD1
isoforms, expressed under conditions such as hypoxia or glu-
cose starvation, that have been proposed to play a critical met-
abolic role in depressing mitochondrial OXPHOS activities to
enable tumor cell survival by promoting hypoxic cellular glyco-
lytic metabolism (8, 9). It is therefore possible that the different
Hig1/HIGD1 isoforms function to differentially regulate or
support the CIV enzyme to respond to different cellular meta-
bolic environments and in a manner that may involve Cox3 and
its lipid modifications.
Experimental procedures
Yeast strains and growth conditions
The Saccharomyces cerevisiae strains used in this study were
WT (W303-1A, Mat a, leu2, trp1, ura3, his3, ade2), rcf1
(W303-1A, Mat a, leu2, trp1, ura3, ade2, RCF1::HIS3), rcf2
(W303-1B, Mat , leu2, trp1, ura3, his3, ade2, RCF2::KAN),
and rcf1;rcf2 (W303-1A, Mat a, leu2, trp1, ura3, ade2,
RCF1::HIS3, RCF2::KAN) (1). Yeast strains were maintained
and cultured using standard protocols at 30 °C on yeast extract/
peptone (YP) media supplemented with 2% glucose and 20
mg/liter adenine hemisulfate (YPAD), YP-0.5% lactate medium
supplemented with 2% galactose (YPGal), or YP-0.5% lactate
medium supplemented with 3% glycerol (YPG), as indicated.
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Yeast cells growing on YPAD agar for less than 24 h were
resuspended in sterile water to A600 nm  0.1, and 10-fold serial
dilutions were made. The cell suspensions (3 l) were spotted
on fresh plates and incubated at 30 °C or 21 °C, as indicated.
Where indicated, the medium was supplemented with 1.0 M
nigericin.
Whole-cell O2 consumption measurements
Yeast strains were grown in YPGal medium and harvested in
their logarithmic phase. Endogenous respiration was measured
the cells (A600  0.6) using a Clark-type oxygen electrode at
30 °C, as described in Ref. 32. Cyanide-sensitive OCRs were
calculated and expressed as percent of the WT control. Results
from two to three independent trials were averaged and
presented.
Mitochondrial O2 consumption measurements
O2 consumption rates were inferred from the decrease in
oxygen concentration measured with a Clark-type O2 electrode
(Rank Brothers Digital Model 10) at 30 °C. Isolated mitochon-
dria (20 – 40 g of protein) resuspended in 0.5 ml of respiration
buffer (0.6 M mannitol, 2 mM MgCl2, 1 mg/ml BSA, 20 mM
HEPES-KOH, 1 mM EDTA, and 10 mM K2PO4 (pH 7.2)) were
added to the O2 electrode chamber. For state 2 measurements,
NADH (1 mM) was added, O2 consumption rates were mea-
sured for 8 min, and average rates were recorded. For state 3
measurements, NADH was followed by ADP (100 –200 M),
and the peak O2 consumption rate (occurring at 4 –5 min) was
recorded. NADHCCCP O2 consumption was measured for 5
min, and average rates were recorded. For measurement of O2
consumption by bioenergetically isolated CIV complex, TMPD
(1.4 mM) plus ascorbate (12.5 mM (pH 7)) in the presence or
absence of CCCP (10 M), as indicated, was added. Baseline of
O2 consumption in the absence of mitochondria with TMPD/
ascorbate was recorded and subtracted.
Measurements of membrane potential in intact mitochondria
Membrane potential () was measured by the decrease in
safranin O fluorescence simultaneously with oxygen consump-
tion at 25 °C using an O2K FluoRespirometer (Oroboros). As a
membrane-permeable cation, safranin crosses to the negative
(matrix) surface of the inner mitochondrial membrane in pro-
portion to the density of negative charge on the inner mem-
brane surface. The association of safranin with the inner surface
of the inner membrane leads to self-quenching of the dye (24).
For each assay, 2.1 ml of yeast mitochondrion assay buffer (0.6
M mannitol, 20 mM MOPS, 10 mM KH2PO4, 5 mM MgCl2, 50
mM KCl, 1 mM EDTA, 0.1 mM EGTA, 2 g/ml catalase, and 1
mg/ml defatted BSA (pH 7.2)) containing 2 M safranin O was
added into an O2K chamber. The fluorescence signal of the
FluoRespirometer was calibrated each day with known concen-
trations of safranin. Hence, the fluorescence readout of the soft-
ware is in units of micromolar safranin, where the concentra-
tion of safranin is that on the outside of the mitochondria. The
addition of 100 –200 g of mitochondria initiated state 2 ET.
The development of  with state 2 ET was seen as a decline in
safranin fluorescence and as a decline in micromolar safranin.
Assays were concluded by addition of 10 M CCCP or 0.9 nmol
valinomycin plus 0.4 M CCCP, which brings  to zero and
safranin fluorescence (as micromolar safranin) to the maxi-
mum for that experiment. The percent safranin uptake at any
time point is calculated as (micromolar safranin at 0  
micromolar safranin at time x)/micromolar safranin at 0 .
The maximum percent safranin uptake value is taken at the
point where safranin fluorescence quenching is greatest.
Estimates of millivolt values for  were derived from the
percent safranin uptake values using the method detailed by
Figueira et al. (33). The millivolt values are considered esti-
mates because it was assumed that the concentration of K in
the matrix of the isolated mitochondria was 120 mM (34). These
safranin uptake and estimated  values are essentially the
same as those obtained using isolated, well-coupled rat liver
mitochondria in similar assays (33).
In assays measuring the  developed by state 2 ET from
NADH to O2, in which CIII and CIV are the components gen-
erating , the maximum safranin fluorescence decrease gen-
erated after addition of 0.5 mM NADH was recorded. In assays
measuring the  developed by state 2 ET through CIV alone,
5 mM ascorbate and 100 M TMPD were added to reduce
endogenous cytochrome c, and 5 M antimycin A was added to
inhibit CIII. High concentrations of TMPD can interfere with
the safranin uptake measurements (reduced TMPD is a lipo-
philic cation) and therefore the TMPD concentration was low-
ered to 100 M in all  determinations.
BN-PAGE analysis
BN-PAGE analysis of digitonin-solubilized (1%) or DDM-
solubilized (0.6%) mitochondrial extracts (30 g of protein) was
performed using Invitrogen NuPAGE gradient (3%-12%) gels
according to the manufacturer’s protocol, followed by Western
blotting and antibody decoration as indicated.
Spectral measurements of cytochrome content
Mitochondrial cytochromes were quantified using a pub-
lished procedure (35) with the following modifications. Isolated
mitochondria were solubilized at a final concentration of 2
mg/ml in the presence of 2% DDM and 50 mM Tris-KCl (pH
7.4) and centrifuged at 10,000 rpm for 5 min. The clarified
supernatant was oxidized with a potassium ferricyanide or
reduced with sodium dithionite, and the difference spectrum
was measured at room temperature. The absorption band cor-
responding to cytochromes aa3 b and c:c1 were quantified using
A603 nm (to account for sloping baseline, a baseline was drawn
through A700 and A630 and extended to 603 nm), A560 nm (base-
line at 575 nm was subtracted), and A550 nm (baseline at 575 nm
was subtracted), respectively. Average and standard error val-
ues are reported and expressed as percent of the WT control.
Spectral measurement of cytochrome bc1 and CIV enzyme
activities
For measurement of the cytochrome bc1 enzyme (NADH 
cytochrome c reductase), mitochondria (20 g) were solubi-
lized with deoxycholate (0.4%), and reduction of horse heart
cytochrome c (66 M) was measured in 10 mM potassium phos-
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phate and 0.1 mM KCN (pH 7.5) following addition of NADH (1
mM), as described in Ref. 1. To determine the relative specific
activity of CIV enzyme in each mitochondrial type, isolated
mitochondria (4 g) were solubilized with DDM (0.05%) and
incubated in 10 mM Tris-HCl and 120 mM KCl (pH 7.0) in the
presence of horse heart cytochrome c (11 M), reduced previ-
ously with 0.5 mM DTT. The activities were monitored spec-
trally at 550 nm, and the resulting relative specific activities
were determined from the initial slopes of the recorded absor-
bance changes at 550 nm (reduction or oxidation of cyto-
chrome c, respectively) and expressed as a percentage of the
WT control.
Statistics and reproducibility
All Western blotting/immunodecorations and serial dilution
growth assays shown are representatives of at least three inde-
pendent replicates. Statistical analysis of enzyme activities and
mitochondrial O2 consumption assays are from a minimum of
three independent experiments and using independent isolated
mitochondrial preparations. Error bars show average 	 S.E.,
and the values were compared with those of respective WT
controls using Student’s t test; p 
 0.05 was considered
significant.
Miscellaneous
Mitochondrial isolation (from cells grown in YPGal
medium), protein determination and SDS-PAGE were per-
formed as described previously (1, 36). Isolated mitochondria
(10 mg/ml) were flash-frozen in liquid nitrogen and stored at
80 °C. Mitochondrial aliquots were thawed and used only
once. The Cox1 and Cox3 antibodies used in this study were
obtained commercially (Cox1: Abcam, anti-yeast Cox1, mouse
monoclonal 11D8-B7; Cox3: Invitrogen/Novex anti-Cox3
monoclonal, 459300). All other antibodies used were rabbit
polyclonal against the respective purified yeast proteins and
generated either in the Stuart laboratory or received as gifts.
Antigen–antibody complexes were detected by horseradish
peroxidase– coupled secondary antibodies and chemilumines-
cence detection on X-ray films, and scanned films were quan-
tified using ImageJ (National Institutes of Health) software.
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